Evgeny Tankhilevich

Evgeny Tankhilevich

Auto-generated profile, based on publicly available information

Evgeny Tankhilevich

European Bioinformatics Institute (EMBL-EBI) , Wellcome Genome Campus , Hinxton, Cambridgeshire, CB10 1SD

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2026 in Bioinformatics
Verified
Journal Article
Open access
ETEvgeny Tankhilevich
Evgeny Tankhilevich
SCSergio Martinez Cuesta
Sergio Martinez Cuesta
IBIan Barrett
Ian Barrett
CBCarolina Berg
Carolina Berg
LSLovisa Holmberg Schiavone
Lovisa Holmberg Schiavone
ALAndrew R Leach
Andrew R Leach
Motivation: Recombinant protein expression can be a limiting step in the production of protein reagents for drug discovery and other biotechnology applications. We introduce RP3Net (Recombinant Protein Production Prediction Network), an AI model of small-scale heterologous soluble protein expression in Escherichia coli. RP3Net utilizes the most recent protein and genomic foundational models. A curated dataset of internal experimental results from AstraZeneca and publicly available data from the Structural Genomics Consortium was used for training, validation and testing of RP3Net. Results: RP3Net achieves an increase in area under the receiver operator curve (AUROC) of 0.15, compared to a baseline model. When experimentally validated on an independent, prospective, manually selected set of 97 constructs, RP3Net outperformed currently available models, with an AUROC of 0.83, delivering accurate predictions in 77% of the cases, and correctly identifying successfully expressing constructs in 92% of cases. Availability and implementation: The model, along with installation and running instructions, is available under an MIT licence at https://github.com/RP3Net/RP3Net, DOI 10.5281/zenodo.17243498.

16 May 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
ETEvgeny Tankhilevich
Evgeny Tankhilevich
SCSergio Martinez Cuesta
Sergio Martinez Cuesta
IBIan Barrett
Ian Barrett
CBCarolina Berg
Carolina Berg
LSLovisa Holmberg Schiavone
Lovisa Holmberg Schiavone
ALAndrew R Leach
Andrew R Leach
Recombinant protein expression can be a limiting step in the production of protein reagents for drug discovery and other biotechnology applications. We introduce RP3Net (Recombinant Protein Production Prediction Network), an AI model of small-scale heterologous soluble protein expression in Escherichia coli . RP3Net utilizes the most recent protein and genomic foundational models. A curated dataset of internal experimental results from AstraZeneca (AZ) and publicly available data from the Structural Genomics Consortium (SGC) was used for training, validation and testing of RP3Net. Set Transformer Pooling (STP) aggregation and Meta Label Correction (MLC) with large scale purification data enabled RP3Net to improve Area Under Receiver Operator Curve (AUROC) by 0.15, compared to the baseline model. When experimentally validated on an independent, manually selected set of 97 constructs, RP3Net outperformed currently available models, with an AUROC of 0.83, delivering accurate predictions in 77% of the cases, and correctly identifying successfully expressing constructs in 92% of cases.

29 September 2026 in Journal of Biological Chemistry
Verified
Journal Article
Open access
CCChristopher Cooper
Christopher Cooper
ETEvgeny Tankhilevich
Evgeny Tankhilevich
KRKim Remans
Kim Remans
AMAhmed El Marjou
Ahmed El Marjou
AEAled M. Edwards
Aled M. Edwards
NBNicola Burgess-Brown
Nicola Burgess-Brown